Chargement en cours...
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity...
Enregistré dans:
| Publié dans: | Antiviral Res |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Author(s). Published by Elsevier B.V.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7129059/ https://ncbi.nlm.nih.gov/pubmed/32251768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104787 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|